Fourth quarter highlights
· Revenue grew 2% underlying and 6% reported to $1,249 million
· Strong trading profit growth, up 7% underlying and 12% reported to $325 million
· 130bps year-on-year increase in trading profit margin, EPSA 25.6¢, up 9%
· Trading cash flow of $366 million, a cash conversion ratio of 113%
· Sustained improvement in US Reconstruction
· Continued higher growth from Emerging & International Markets
Full Year highlights
· Revenue grew 2% underlying and 6% reported to $4,617 million
· Trading profit up 3% underlying and 7% reported to $1,055 million
· Improved year-on-year trading profit margin, up 20bps to 22.9%, EPSA 83.2¢, up 8%
· ArthroCare Corporation acquisition completed for $1.7 billion, reinforcing Sports Medicine
· Proposed Final Dividend of 18.6¢, Full Year distribution of 29.6¢ per share, up 8% year-on-year
